Monashee Investment Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Monashee Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$46.59 - $66.96 $990,456 - $1.42 Million	21,259 New	21,259 $1.4 Million
Q2 2022 Aug 12, 2022	SELL	$35.07 - $59.21 $861,143 - $1.45 Million	-24,555 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$35.46 - $54.12 $870,720 - $1.33 Million	24,555 New	24,555 $1.25 Million
Q2 2019 Aug 07, 2019	SELL	$18.0 - $25.34 $786,600 - $1.11 Million	-43,700 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.81 - $19.82 $559,797 - $866,134	43,700 New	43,700 $852,000

300

111M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.67B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.